Validated platform across more than 12 peer-reviewed publications

We take the opportunity to work with forward looking researchers to demonstrate the clinical value of our platform to patients, physicians and healthcare systems. And we are just getting started.

Real-World-Data from our engagements reveals great health economic outcome potential and staggering acceptance

9.4 - Acceptance of NuvoAir solution on a scale from 0 to 10

Booked
Consultations

Urgent
Consultations

Improved understanding
of their condition

Improved
medication adherence

ePS1.07 Patient experience of virtual consultations: survey results, Journal of Cystic Fibrosis Volume 19, Supplement 2, June 2020, Page s39

Our Partners

Hospitals, universities, pharma companies and CROs around the world have chosen NuvoAir as their respiratory partner. We’re proud to support the work of forward-thinking, innovative players and researchers.

Seattle Children's Hospital
Roche
HNS Royal Brompton & Harefield
Regeneron
Novartis
NHS King's College Hospital
Dartmouth-Hitchcock
Boston Children's Hospital
InterMedCon Gmbh